Skip Navigation
Review our

Clinical Trials

Learn more about our ongoing clinical trials.

Closed to enrollment
A Multicenter, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Evaluate the Safety and Maintenance of Efficacy of Ecopipam in Children, Adolescents and Adults With Tourette’s Disorder
Closed to enrollment
A Multicenter, Open-Label, Extension Study Intended to Evaluate the Long-term Safety of Ecopipam Tablets in Children and Adolescent Subjects With Tourette’s Syndrome
Closed to enrollment
A Multicenter, Open-Label, Study to Evaluate the Long-term Safety of Ecopipam Tablets in Children, Adolescents and Adults With Tourette’s Disorder
Closed to enrollment
Multicenter, Placebo-Controlled, Double-Blind, Randomized, Parallel-Group, Phase 2b Study to Evaluate the Efficacy and Safety of Ecopipam in Children and Adolescents With Tourette’s Syndrome
Related Links
EAP Policy
Pipeline
Find Your MSL